Efficacy and safety of hydrolyzed rice-protein ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow''s milk protein allergy.
Author(s) :
Bocquet, A [Auteur]
Université de Franche-Comté [UFC]
Dupont, C [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Chouraqui, Jean-Pierre [Auteur]
Darmaun, D [Auteur]
Université de Nantes [UN]
Feillet, F [Auteur]
Université de Lorraine [UL]
Frelut, M-L [Auteur]
Girardet, J-P [Auteur]
Université Pierre et Marie Curie - Paris 6 [UPMC]
Hankard, R [Auteur]
Université de Tours [UT]
Niche, Nutrition, Cancer et métabolisme oxydatif [N2Cox]
Lapillonne, A [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Roze, J-C [Auteur]
Université de Nantes [UN]
Simeoni, Umberto [Auteur]
Université de Lausanne = University of Lausanne [UNIL]
Turck, Turck [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Briend, A [Auteur]
Institut de Recherche pour le Développement [IRD]
Université de Franche-Comté [UFC]
Dupont, C [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Chouraqui, Jean-Pierre [Auteur]
Darmaun, D [Auteur]
Université de Nantes [UN]
Feillet, F [Auteur]
Université de Lorraine [UL]
Frelut, M-L [Auteur]
Girardet, J-P [Auteur]
Université Pierre et Marie Curie - Paris 6 [UPMC]
Hankard, R [Auteur]
Université de Tours [UT]
Niche, Nutrition, Cancer et métabolisme oxydatif [N2Cox]
Lapillonne, A [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Roze, J-C [Auteur]
Université de Nantes [UN]
Simeoni, Umberto [Auteur]
Université de Lausanne = University of Lausanne [UNIL]
Turck, Turck [Auteur]

Lille Inflammation Research International Center - U 995 [LIRIC]
Briend, A [Auteur]
Institut de Recherche pour le Développement [IRD]
Journal title :
Archives de Pédiatrie
Abbreviated title :
Arch Pediatr
Volume number :
26
Pages :
238-246
Publication date :
2019-05
ISSN :
1769-664X
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Foods for special medical purposes (FSMPs) with a protein fraction made of hydrolyzed rice protein (HRPs) have been on the market in Europe since the 2000s for the treatment of cow's milk protein allergy (CMPA). HRP formulas ...
Show more >Foods for special medical purposes (FSMPs) with a protein fraction made of hydrolyzed rice protein (HRPs) have been on the market in Europe since the 2000s for the treatment of cow's milk protein allergy (CMPA). HRP formulas (HRPFs) are proposed as a plant-based alternative to cow's milk protein-based extensively hydrolyzed formulas (CMP-eHF) beside the soy protein formulas whose use in CMPA is controversial. HRPFs do not contain phytoestrogens and are derived from non-genetically modified rice. HRPFs are strictly plant-based apart from the addition of vitamin D (cholecalciferol). As the amino acid content of rice proteins differs from that of human milk proteins, the protein quality of these formulas is improved by supplementation with free lysine, threonine, and tryptophan. The consumption of HRPFs has risen: for example, in France HRPFs account for 4.9% in volume of all formulas for children aged 0-3 years. Several studies have shown the adequacy of HRPFs in treating CMPA. They ensure satisfactory growth from the 1st weeks of life for infants and toddlers, both in healthy children and in those with CMPA. HRPFs can be used to treat children with CMPA either straightaway or in second intention in cases of poor tolerance to CMP-eHF for organoleptic reasons or for lack of efficacy. In France, the cost of HRPFs is close to that of regular infant or follow-on formulas.Show less >
Show more >Foods for special medical purposes (FSMPs) with a protein fraction made of hydrolyzed rice protein (HRPs) have been on the market in Europe since the 2000s for the treatment of cow's milk protein allergy (CMPA). HRP formulas (HRPFs) are proposed as a plant-based alternative to cow's milk protein-based extensively hydrolyzed formulas (CMP-eHF) beside the soy protein formulas whose use in CMPA is controversial. HRPFs do not contain phytoestrogens and are derived from non-genetically modified rice. HRPFs are strictly plant-based apart from the addition of vitamin D (cholecalciferol). As the amino acid content of rice proteins differs from that of human milk proteins, the protein quality of these formulas is improved by supplementation with free lysine, threonine, and tryptophan. The consumption of HRPFs has risen: for example, in France HRPFs account for 4.9% in volume of all formulas for children aged 0-3 years. Several studies have shown the adequacy of HRPFs in treating CMPA. They ensure satisfactory growth from the 1st weeks of life for infants and toddlers, both in healthy children and in those with CMPA. HRPFs can be used to treat children with CMPA either straightaway or in second intention in cases of poor tolerance to CMP-eHF for organoleptic reasons or for lack of efficacy. In France, the cost of HRPFs is close to that of regular infant or follow-on formulas.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Inserm
Université de Lille
Inserm
Université de Lille
Submission date :
2019-10-22T07:44:19Z
2023-12-08T15:37:14Z
2023-12-08T15:37:14Z
Files
- document
- Open access
- Access the document